FDA Inspection 957613 — BioSpectra, Inc.
The FDA completed an inspection of BioSpectra, Inc. on January 29, 2016 in Bangor, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 29, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Bangor, PA (United States)